Sign In
Register
eISSN:2278-5299

International Journal of Latest Research in Science and Technology

DOI:10.29111/ijlrst   ISRA Impact Factor:3.35

A News Letter Sign UP!
Prognostic value of high DDX39 expression in esophageal squamous cell carcinoma

Research Paper Open Access

International Journal of Latest Research in Science and Technology Vol.7 Issue 3, pp 19-23,Year 2018

PROGNOSTIC VALUE OF HIGH DDX39 EXPRESSION IN ESOPHAGEAL SQUAMOUS CELL CARCINOMA

JianXian Huang,JieCheng Ye,XueYun Zhong

Correspondence should be addressed to :

Received : 08 June 2018; Accepted : 16 June 2018 ; Published : 27 June 2018

Share
Download 125
View 177
Article No. 10942
Abstract

Background: This study was aimed to validate a prognostic biomarker, adenosine triphosphate-dependent RNA helicase DDX39, in esophageal squamous cell carcinoma (ESCC). Novel prognostic biomarkers may help design more effective treatments for ESCC in the clinic. Methods: The expression level of DDX39 was bioinformatically detected and immunohistochemically examined in 95 ESCC cases. Correlation analyses were performed by χ2 test between DDX39 expression and clinicopathological parameters, and univariate analyses were performed to assess the prognostic value of DDX39 expression in ESCC. Results: Bioinformatics analysis showed DDX39 upregulated in esophageal cancer , while immunohistochemical study revealed that 61.1% of the 95 patients showed high DDX39 expression in ESCC tissues, and univariate analyses demonstrated that DDX39 expression was a prognostic factor in ESCC. Conclusions: These results established the clinical utility of DDX39 expression as a novel prognostic biomarker in ESCC, suggesting that DDX39 may be a potential therapeutic target for treating ESCC patients with elevated DDX39 expression.

Key Words   
Esophageal squamous cell carcinoma, DDX39, survival analysis

Copyright
References
  1. Fitzmaurice, Dicker, Pain, et al. The global burden of cancer 2013. JAMA Oncol. 2015; 1(4): 505–527.
  2. He Liang, Jin-Hu Fan, You-Lin Qiao. Epidemiology, etiology, and prevention of esophageal squamous cell carcinoma in China. Cancer Biol Med, 2017; 14: 33-41.
  3. Jing Xu, Yanhua Chen, Ruiping Zhang, et al. Global and Targeted Metabolomics of Esophageal Squamous Cell Carcinoma Discovers Potential Diagnostic and Therapeutic Biomarkers. Cell. Proteomics, 2013; 12: 1306-1318.
  4. Harwood, C.A., et al., The Promise of Genomics and the Development of Targeted Therapies for Cutaneous Squamous Cell Carcinoma. Acta Derm Venereol, 2016. 96(1): 3-16.
  5. Linder, P.F. Lasko, M. Ashburner, P. Leroy, P.J. Nielsen, K.Nishi, J. Schnier, P.P. Slonimski, Birth of the D-E-A-D box, Nature, 1989; 337: 121–122.
  6. Gaouar, O. and H. Germain, mRNA export: threading the needle. Frontiers In Plant Science, 2013. 1-5.
  7. Sugiura, T., Y. Nagano, and Y. Noguchi, DDX39, upregulated in lung squamous cell cancer, displays RNA helicase activities and promotes cancer cell growth. Cancer Biology & Therapy, 2014; 6(6): 957-964.
  8. Kikuta, K., et al., Clinical proteomics identified ATP-dependent RNA helicase DDX39 as a novel biomarker to predict poor prognosis of patients with gastrointestinal stromal tumor. J Proteomics, 2012; 75(4): 1089-98.
  9. Kubota, D., et al., Validation Study on Pfetin and ATP-dependent RNA Helicase DDX39 as Prognostic Biomarkers in Gastrointestinal Stromal Tumour. Japanese Journal Of Clinical Oncology, 2012. 42(8): 730-741.
  10. Kato, M., et al., DDX39 acts as a suppressor of invasion for bladder cancer. Cancer Sci, 2012; 103(7): 1363-9.
  11. Yoo, H.H. and I.K. Chung, Requirement of DDX39 DEAD box RNA helicase for genome integrity and telomere protection. Aging Cell, 2011; 10(4): 557-571.
  12. Palm W, de Lange T. How shelterin protects mammalian telomeres. Annu. Rev. Genet. 2008; 42: 301–334.
  13. Liu, Y., et al., Personalized and targeted therapy of esophageal squamous cell carcinoma: an update. Ann N Y Acad Sci, 2016. 1381(1): p. 66-73.
  14. Izadpanah, M.H., et al., Ectopic expression of TWIST1 upregulates the stemness marker OCT4 in the esophageal squamous cell carcinoma cell line KYSE30. Cell Mol Biol Lett, 2017. 22: 33.
  15. Sugiura T, Sakurai K and Nagano Y: Intracellular characterization of DDX39, a novel growth-associated RNA helicase. Exp Cell Res 2007; 313: 782-790.
  16. Cruz J, Kressler D and Linder P. Unwinding RNA in Saccharomyces cerevisiae: DEAD-box proteins and related families. Trends Biochem Sci 1999; 24: 192-198.
  17. Rocak S and Linder P. DEAD-box proteins: The driving forces behind RNA metabolism. Nat Rev Mol Cell Biol 2004; 5: 232-241.
  18. Sarkar, M. and M.K. Ghosh, DEAD box RNA helicases: crucial regulators of gene expression and oncogenesis. Frontiers In Bioscience-Landmark, 2016; 21: 225-250.
  19. Li, B., et al., Knockdown of DDX46 inhibits proliferation and induces apoptosis in esophageal squamous cell carcinoma cells. Oncol Rep, 2016; 36(1): 223-30.
  20. YASUHIRO KURAMITSU, S.S., YUFENG WANG,et al. Up-regulation of DDX39 in Human Pancreatic Cancer Cells with Acquired Gemcitabine Resistance Compared to Gemcitabine-sensitive Parental Cells. Anticancer Research, 2013; 33: 3133-3136.
  21. Naboulsi, W., et al., Quantitative Tissue Proteomics Analysis Reveals Versican as Potential Biomarker for Early-Stage Hepatocellular Carcinoma. Journal Of Proteome Research, 2016; 15(1): 38-47.
  22. Otake, K., et al., Identification of DDX39A as a Potential Biomarker for Unfavorable Neuroblastoma Using a Proteomic Approach. Pediatric Blood & Cancer, 2016; 63(2): 221-227.
To cite this article

JianXian Huang,JieCheng Ye,XueYun Zhong , " Prognostic Value Of High Ddx39 Expression In Esophageal Squamous Cell Carcinoma ", International Journal of Latest Research in Science and Technology . Vol. 7, Issue 3, pp 19-23 , 2018

Responsive image

MNK Publication was founded in 2012 to upholder revolutionary ideas that would advance the research and practice of business and management. Today, we comply with to advance fresh thinking in latest scientific fields where we think we can make a real difference and growth now also including medical and social care, education,management and engineering.

Responsive image

We offers several opportunities for partnership and tie-up with individual, corporate and organizational level. We are working on the open access platform. Editors, authors, readers, librarians and conference organizer can work together. We are giving open opportunities to all. Our team is always willing to work and collaborate to promote open access publication.

Responsive image

Our Journals provide one of the strongest International open access platform for research communities. Our conference proceeding services provide conference organizers a privileged platform for publishing extended conference papers as journal publications. It is deliberated to disseminate scientific research and to establish long term International collaborations and partnerships with academic communities and conference organizers.